Table 2.
Comparison of proteinuria, hematuria and eGFR between recurrence and non-recurrence, according to timing of measurement
| Variables | Timing | Outcome | P valuea | |
|---|---|---|---|---|
| Recurrence | Non-recurrence | |||
| UPE, g/day* | 0 year | 1.07 (0.70–1.64) | 0.79 (0.50–1.23) | 0.039# |
| 1 year | 0.20 (0.12–0.30) | 0.18 (0.09–0.27) | >0.2 | |
| Last observation | 1.18 (1.00–1.40) | 0.15 (0.10–0.30) | 0.001# | |
| Hematuria** | 0 year | 14 (51.9) | 44 (59.5) | >0.2 |
| 1 year | 11 (40.7) | 30 (40.5) | >0.2 | |
| Last observation | 22 (81.5) | 22 (29.7) | 0.001# | |
| eGFR, ml/min/1.73 m2*** | 0 year | 62.2 ± 21.5 | 79.8 ± 28.2 | 0.004# |
| 1 year | 63.7 ± 21.1 | 81.0 ± 27.9 | 0.004# | |
| Last observation | 58.9 ± 21.4 | 74.0 ± 23.8 | 0.005# | |
UPE urine protein excretion volume, eGFR estimated glomerular filtration rate
* Values are presented as median and interquartile range
** Values are presented as number of patients (%) with U-RBC ≥30/hpf at start of treatment and U-RBC ≥5/hpf at 1 year after treatment or last observation, respectively. *** Values are presented as mean and standard deviation.a Recurrence vs Non-recurrence. # P < 0.05